English   español  

Browsing by Author Bové, Jordi

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
RightsPreviewIssue DateTitleAuthor(s)Type
closedAccessaccesoRestringido.pdf.jpg11-May-2017Alterations in CD200-CD200R1 and CX3CL1-CX3CR1 systems in the acute MPTP mouse model of Parkinson's diseaseRabaneda, Neus; Serratosa, Joan ; Bové, Jordi; Vila, M.; Saura, Josep ; Solà, Carme póster de congreso
openAccessBrain tyrosinase_CarballoCarbajal.pdf.jpg7-Mar-2019Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesisCarballo-Carbajal, Iria; Laguna, Ariadna; Romero-Giménez, Jordi; Cuadros, Thais; Bové, Jordi; Martinez-Vicente, Marta; Parent, Annabelle; González-Sepúlveda, Marta; Peñuelas, Nuria; Torra, Albert; Rodríguez-Galván, Beatriz; Ballabio, Andrea; Hasegawa, Takafumi; Bortolozzi, Analía ; Gelpi, Ellen; Vila, Miquelartículo
openAccessFunctional Rescue of Dopaminergic-Altarche.pdf.jpgJun-2016Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor CellsAltarche-Xifro, Wassim; di Vicino, Umberto; Muñoz-Martín, María Isabel; Bortolozzi, Analía ; Bové, Jordi; Vila, M.; Cosma, María Píaartículo
closedAccessaccesoRestringido.pdf.jpg8-Jul-2017Glial activation and its mechanisms of control in the MPTP mouse model of Parkinson's diseaseRabaneda, Neus; Serratosa, Joan ; Bové, Jordi; Vila, M.; Saura, Josep ; Solà, Carme póster de congreso
closedAccessaccesoRestringido.pdf.jpg2011Lysosomal membrane permeabilization in Parkinson diseaseVila, M.; Bové, Jordi; Dehay, Benjamin; Rodríguez-Muela, N. ; Boya, Patricia  artículo
closedAccessaccesoRestringido.pdf.jpgAug-2005Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: Effect on the activity of striatal output pathwaysBové, Jordi; Serrats, Jordi; Mengod Los Arcos, Guadalupe ; Cortés, Roser ; Tolosa, Eduardo; Marín, Concepcióartículo
closedAccessaccesoRestringido.pdf.jpg6-Jun-2018Overexpression of TFEB drives a pleiotropic neurotrophic effect and prevents parkinson's disease-related neurodegenerationTorra, Alber; Parent, Annabelle; Cuadros, Thais; Rodríguez-Galván, Beatriz; Ruiz-Bronchal, Esther; Ballabio, Andrea; Bortolozzi, Analía ; Vila, Miquel; Bové, Jordiartículo
closedAccessrestringido.pdf.jpg15-Sep-2010Pathogenic lysosomal depletion in Parkinson´s diseaseDehay, Benjamin; Bové, Jordi; Rodríguez-Muela, N. ; Perier, Céline; Recasens, Ariadna; Boya, Patricia  ; Vila, M.artículo
closedAccessaccesoRestringido.pdf.jpg2008Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of miceGranado, Noelia ; O'Shea, E.; Bové, Jordi; Vila, Miquel; Colado, M. I.; Moratalla, Rosario  artículo
closedAccessaccesoRestringido.pdf.jpg23-Feb-2006Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned ratsBové, Jordi; Serrats, Jordi; Mengod Los Arcos, Guadalupe ; Cortés, Roser ; Aguilar, Esther; Marín, Concepcióartículo
closedAccessaccesoRestringido.pdf.jpg9-Dec-2013Selective suppression of α-Synuclein in monoaminergic neurons of mice by intranasal delivery of targeted small interfering RNA or antisense oligonucleotides: Potential therapy for Parkinson's diseaseRecasens, Ariadna; Galofré, Mireia ; Carballo-Carbajal, Iria; Ferrés-Coy, Albert ; Bové, Jordi; Perier, Céline; Carmona, María del Carmen; Santos, M. I.; Baena, S.; Chica, M. Rosario; Montefeltro, Andrés; Revilla, Raquel; Bortolozzi, Analía póster de congreso
closedAccessaccesoRestringido.pdf.jpg12-Nov-2018The CD200R1 microglial inhibitory receptor as potential target to control neuroinflammation and resulting neuronal damage in the MPTP mouse model of Parkinson's diseaseRabaneda, Neus; Serratosa, Joan ; Bové, Jordi; Vila, M.; Saura, Josep ; Solà, Carme comunicación de congreso
closedAccessaccesoRestringido.pdf.jpgJan-2005The kappa opioid agonist U50,488 potentiates 6-hydroxydopamine-induced neurotoxicity on dopaminergic neuronsMarín, Concepció; Bové, Jordi; Serrats, Jordi; Cortés, Roser ; Mengod Los Arcos, Guadalupe ; Tolosa, Eduardoartículo